Windtree Therapeutics, a biotech and BNB treasury firm, saw its shares crash 77% on Wednesday. The sharp drop followed a notice from the Nasdaq Stock Market, which informed the company it would be delisted for failing to meet listing requirements. In a filing to the US Securities and Exchange Commission (SEC) on Tuesday, Windtree confirmed […]
The post Windtree Shares Collapse 77% After Nasdaq Delisting Notice Over BNB Treasury Strategy appeared first on CoinChapter.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.